Biocon informs about press release

23 Nov 2017 Evaluate

Biocon has informed about Press Release titled ‘Biocon Launches KRABEVA- Biosimilar Bevacizumab for Treating Several Types of Cancer in India.’

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

379.80 -0.45 (-0.12%)
17-Feb-2026 13:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.85
Dr. Reddys Lab 1276.70
Cipla 1342.70
Zydus Lifesciences 905.95
Lupin 2239.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×